Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE5.9000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.3600/ 2
- Ask / Lots5.9200/ 2
- Open / Previous Close--- / 5.9000
- Day Range---
- 52 Week Range
- Volume24
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 9135 | 5.9 |
| 09:33 ET | 6748 | 5.9 |
| 09:35 ET | 100 | 5.9 |
| 09:37 ET | 100 | 5.845 |
| 09:39 ET | 2001 | 5.8869 |
| 09:44 ET | 100 | 5.895 |
| 09:46 ET | 300 | 5.85 |
| 09:48 ET | 1600 | 5.905 |
| 09:50 ET | 525 | 5.855 |
| 09:53 ET | 3398 | 5.8196 |
| 09:55 ET | 1950 | 5.77 |
| 09:57 ET | 100 | 5.76 |
| 10:00 ET | 500 | 5.77 |
| 10:02 ET | 4100 | 5.775 |
| 10:08 ET | 200 | 5.745 |
| 10:09 ET | 100 | 5.73 |
| 10:11 ET | 500 | 5.71 |
| 10:13 ET | 1000 | 5.72 |
| 10:15 ET | 1200 | 5.702 |
| 10:22 ET | 300 | 5.74 |
| 10:24 ET | 1000 | 5.755 |
| 10:26 ET | 181 | 5.75 |
| 10:29 ET | 2671 | 5.6613 |
| 10:31 ET | 640 | 5.675 |
| 10:33 ET | 345 | 5.673 |
| 10:36 ET | 600 | 5.69 |
| 10:38 ET | 200 | 5.705 |
| 10:47 ET | 300 | 5.73 |
| 10:51 ET | 539 | 5.76 |
| 10:54 ET | 9179 | 5.79 |
| 10:58 ET | 200 | 5.8 |
| 11:02 ET | 999 | 5.78 |
| 11:05 ET | 100 | 5.78 |
| 11:07 ET | 200 | 5.77 |
| 11:09 ET | 2300 | 5.77 |
| 11:12 ET | 200 | 5.76 |
| 11:16 ET | 1835 | 5.76 |
| 11:18 ET | 824 | 5.77 |
| 11:21 ET | 7700 | 5.73 |
| 11:30 ET | 2157 | 5.7399 |
| 11:36 ET | 3780 | 5.76 |
| 11:38 ET | 300 | 5.74 |
| 11:39 ET | 1301 | 5.74 |
| 11:41 ET | 200 | 5.74 |
| 11:43 ET | 900 | 5.72 |
| 11:45 ET | 1227 | 5.74 |
| 11:48 ET | 300 | 5.735 |
| 11:50 ET | 1285 | 5.715 |
| 11:52 ET | 2175 | 5.725 |
| 11:57 ET | 100 | 5.725 |
| 11:59 ET | 100 | 5.74 |
| 12:01 ET | 200 | 5.725 |
| 12:03 ET | 100 | 5.74 |
| 12:06 ET | 563 | 5.74 |
| 12:08 ET | 400 | 5.76 |
| 12:10 ET | 100 | 5.76 |
| 12:12 ET | 2200 | 5.79 |
| 12:15 ET | 200 | 5.79 |
| 12:17 ET | 117 | 5.7805 |
| 12:19 ET | 200 | 5.8 |
| 12:21 ET | 600 | 5.8 |
| 12:24 ET | 100 | 5.8 |
| 12:26 ET | 421 | 5.8 |
| 12:28 ET | 400 | 5.8 |
| 12:30 ET | 900 | 5.805 |
| 12:32 ET | 600 | 5.825 |
| 12:37 ET | 300 | 5.84 |
| 12:39 ET | 100 | 5.84 |
| 12:42 ET | 100 | 5.84 |
| 12:44 ET | 1175 | 5.86 |
| 12:48 ET | 2962 | 5.89 |
| 12:50 ET | 1697 | 5.87 |
| 12:51 ET | 200 | 5.865 |
| 12:53 ET | 1500 | 5.865 |
| 12:55 ET | 305 | 5.85 |
| 01:00 ET | 545 | 5.845 |
| 01:02 ET | 100 | 5.85 |
| 01:04 ET | 1870 | 5.855 |
| 01:08 ET | 3698 | 5.79 |
| 01:13 ET | 500 | 5.76 |
| 01:18 ET | 200 | 5.77 |
| 01:22 ET | 459 | 5.784 |
| 01:24 ET | 100 | 5.8 |
| 01:26 ET | 200 | 5.8 |
| 01:27 ET | 700 | 5.8 |
| 01:29 ET | 100 | 5.795 |
| 01:31 ET | 1404 | 5.85 |
| 01:33 ET | 600 | 5.86 |
| 01:36 ET | 100 | 5.86 |
| 01:40 ET | 688 | 5.87 |
| 01:42 ET | 300 | 5.88 |
| 01:44 ET | 300 | 5.845 |
| 01:45 ET | 800 | 5.85 |
| 01:47 ET | 1662 | 5.84 |
| 01:49 ET | 900 | 5.85 |
| 01:51 ET | 300 | 5.85 |
| 01:54 ET | 2090 | 5.84 |
| 01:56 ET | 509 | 5.845 |
| 01:58 ET | 1100 | 5.855 |
| 02:00 ET | 1600 | 5.86 |
| 02:02 ET | 2762 | 5.85 |
| 02:03 ET | 200 | 5.85 |
| 02:05 ET | 300 | 5.85 |
| 02:07 ET | 600 | 5.85 |
| 02:09 ET | 500 | 5.85 |
| 02:12 ET | 1723 | 5.84 |
| 02:14 ET | 400 | 5.85 |
| 02:16 ET | 284 | 5.85 |
| 02:18 ET | 100 | 5.85 |
| 02:25 ET | 1071 | 5.8699 |
| 02:27 ET | 2258 | 5.875 |
| 02:32 ET | 100 | 5.875 |
| 02:34 ET | 100 | 5.875 |
| 02:36 ET | 300 | 5.88 |
| 02:38 ET | 2078 | 5.9 |
| 02:39 ET | 400 | 5.89 |
| 02:41 ET | 100 | 5.92 |
| 02:45 ET | 100 | 5.93 |
| 02:50 ET | 2403 | 5.9 |
| 02:52 ET | 699 | 5.905 |
| 02:56 ET | 1499 | 5.905 |
| 02:57 ET | 750 | 5.895 |
| 02:59 ET | 3400 | 5.88 |
| 03:01 ET | 100 | 5.88 |
| 03:08 ET | 1100 | 5.915 |
| 03:10 ET | 100 | 5.93 |
| 03:12 ET | 2473 | 5.965 |
| 03:14 ET | 260 | 5.97 |
| 03:15 ET | 100 | 5.98 |
| 03:17 ET | 2440 | 5.98 |
| 03:19 ET | 3215 | 6 |
| 03:21 ET | 1373 | 6.03 |
| 03:24 ET | 100 | 6.03 |
| 03:26 ET | 911 | 6.0291 |
| 03:28 ET | 6837 | 6.015 |
| 03:30 ET | 750 | 5.985 |
| 03:32 ET | 2000 | 5.99 |
| 03:33 ET | 4028 | 5.95 |
| 03:37 ET | 2218 | 5.935 |
| 03:39 ET | 700 | 5.93 |
| 03:42 ET | 300 | 5.93 |
| 03:44 ET | 100 | 5.93 |
| 03:46 ET | 300 | 5.94 |
| 03:48 ET | 200 | 5.93 |
| 03:50 ET | 1336 | 5.9595 |
| 03:51 ET | 2275 | 5.93 |
| 03:53 ET | 800 | 5.945 |
| 03:55 ET | 5010 | 5.9501 |
| 03:57 ET | 2337 | 5.915 |
| 04:00 ET | 32151 | 5.9 |
Nov 15, 2024
DJ Kodiak Sciences Is Maintained at Underweight by Barclays, from 10:01AM ET on Friday Nov 15, 2024 by Dow Jones
10:01AM ET on Friday Nov 15, 2024 by Dow JonesDJ Kodiak Sciences Price Target Maintained With a $3.00/Share by HC Wainwright & Co., from 6:31AM ET on Friday Nov 15, 2024 by Dow Jones
6:31AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 14, 2024
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results, from 4:01PM ET on Thursday Nov 14, 2024 by Dow Jones
4:01PM ET on Thursday Nov 14, 2024 by Dow Jones*DJ Kodiak Sciences 3Q Loss/Shr 84c >KOD, from 4:01PM ET on Thursday Nov 14, 2024 by Dow Jones
4:01PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 11, 2024
Kodiak Sciences to Participate in Upcoming Investor Conferences, from 6:15AM ET on Monday Nov 11, 2024 by Dow Jones
6:15AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 310.4M | -1.6x | --- |
Design Therapeutics Inc | 315.4M | -6.6x | --- |
Compass Pathways PLC | 304.5M | -2.0x | --- |
Nautilus Biotechnology Inc | 298.8M | -4.2x | --- |
Jasper Therapeutics Inc | 327.6M | -4.6x | --- |
Aldeyra Therapeutics Inc | 286.4M | -6.4x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Lead Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $310.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.29 |
EPS | $-3.65 |
Book Value | $5.06 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
